#19831
Re: Novavax (NVAX): Un Nuevo Comienzo
JNJ
In our hospitalization network, so in our active surveillance that looks at vaccine effectiveness in hospitalized individuals, we demonstrated that the Janssen vaccine was only 68% effective against hospitalization, and this is in adults greater than 18 years of age without immunocompromising conditions, which is both lower than what we saw from that real-world effectiveness presentation and it is also substantially lower than the mRNA vaccines are against hospitalization even with the waning.
https://twitter.com/HelenBranswell/status/1449066049320718341?t=Gx-yBSLoKA0oc-yVEYiYsg&s=19
In our hospitalization network, so in our active surveillance that looks at vaccine effectiveness in hospitalized individuals, we demonstrated that the Janssen vaccine was only 68% effective against hospitalization, and this is in adults greater than 18 years of age without immunocompromising conditions, which is both lower than what we saw from that real-world effectiveness presentation and it is also substantially lower than the mRNA vaccines are against hospitalization even with the waning.
https://twitter.com/HelenBranswell/status/1449066049320718341?t=Gx-yBSLoKA0oc-yVEYiYsg&s=19